Prevalence and predictors of dyspnea in acute coronary syndrome patients receiving ticagrelor: A prospective cohort study in Iran
Maryam Taherkhani, Naimeh Kord, Adineh Taherkhani, Niloofar Shirazi, Arian Tavasol · 2026
Read Prevalence and predictors of dyspnea in acute coronary syndrome patients receiving ticagrelor: A prospective cohort study in Iran by Maryam Taherkhani, Naimeh Kord, Adineh Taherkhani, Niloofar Shirazi, Arian Tavasol (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13166619.txt.
Description
Maryam Taherkhani and co-authors measure how often breathlessness occurs in heart patients who take ticagrelor. Their 2026 prospective cohort study is set in Iran and deals with acute coronary syndrome, where dyspnea is a hard symptom to judge.
Ticagrelor helps prevent ischemic events and death, but it can also cause dyspnea. The study followed 200 patients at Modarres Hospital from March 2020 to March 2022. Breathlessness and its severity were scored daily in hospital with the modified Borg scale, and patients were followed for three months after discharge. The team also sought factors that predict who will develop this side effect.
Catalog record
| CREATOR | Maryam Taherkhani, Naimeh Kord, Adineh Taherkhani, Niloofar Shirazi, Arian Tavasol |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |